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The complete nucleotide sequences of eight West Nile (WN) virus strains (Egypt 1951, Romania 1996-MQ, Italy 1998-
equine, New York 1999-equine, MD 2000-crow265, NJ 2000MQ5488, NY 2000-grouse3282, and NY 2000-crow3356) were
determined. Phylogenetic trees were constructed from the aligned nucleotide sequences of these eight viruses along with
all other previously published complete WN virus genome sequences. The phylogenetic trees revealed the presence of two
genetic lineages of WN viruses. Lineage 1 WN viruses have been isolated from the northeastern United States, Europe, Israel,
Africa, India, Russia, and Australia. Lineage 2 WN viruses have been isolated only in sub-Saharan Africa and Madagascar.INTRODUCTION
West Nile (WN) virus is a single-stranded plus-sense
RNA virus that is taxonomically classified within the
family Flaviviridae, genus Flavivirus. The virus was orig-
inally isolated in 1937 from a febrile human who resided
in the West Nile District of Uganda (Smithburn et al.,
1940). Initial cross-neutralization experiments demon-
strated that the virus was serologically related to Japa-
nese encephalitis virus (JE) (Smithburn et al., 1940).
Since that time, hemaglutination inhibition and cross-
neutralization data have demonstrated that WN virus is a
member of the JE virus serocomplex, which includes JE,
St. Louis encephalitis, and Murray Valley encephalitis
(MVE) viruses (Murphy et al., 1995). WN virus circulates
in natural transmission cycles involving primarily Culex
species mosquitoes and birds, and humans are inciden-
tal hosts. Mild or subclinical human infections in en-
demic areas are common; in one study, seroprevalence
among adults in the Nile Delta region was shown to be
61% with little or no evidence of disease (Taylor et al.,
1956). However, significant WN epidemics, which in-
cluded encephalitis and death, have been reported in
Israel (1950s), France (1962), South Africa (1974), India
(1980/1981), and Romania (1996) (Hayes, 1989; Savage et
al., 1999; Tsai et al., 1998). In 1999 and 2000, WN virus
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96was responsible for epidemics in the northeastern
United States, Volgograd, Russia, and Israel (Prilipov et
al., 2001; CDC, 2000, 2001; Lanciotti et al., 1999). Concur-
rent with the epidemics in the United States, an epizootic
occurred in which substantial numbers of wild birds and
equines died (Komar, 2000; Trock et al., 2001).
Previous serological and molecular studies conducted
on WN virus isolates have revealed that significant strain
variation exists among WN viruses. Kinetic HI analysis
revealed that WN virus strains from India were distinct
from WN viruses from Africa, the Middle East, and
France (Hammam et al., 1965; Price and O’Leary, 1967).
Monoclonal antibody-binding assays have also shown
that strains from the Central African Republic were dis-
tinct from the prototype Egypt 1951 strain (Umrigar and
Pavri, 1977). More recently, phylogenetic analysis per-
formed on nucleic acid sequence data from a portion of
the envelope gene has demonstrated that two distinct
lineages of WN viruses exist. Viruses in lineage 1 have a
worldwide distribution, ranging from western Africa, the
Middle East, Eastern Europe, the United States, and
Australia, whereas lineage 2 consists exclusively of vi-
ruses from the African continent (Savage et al., 1999;
Lanciotti et al., 1999; Berthet et al., 1997). In addition,
within lineage 1, Kunjin and the Indian WN viruses exist
as separate clades. To extend these findings and to
determine more precisely the relationships between theLineage 1 viruses can be further subdivided into three mo
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WN viruses currently circulating in the United States and
other WN virus strains, the complete genomic se-nophyle
ysis; nu
quences of eight WN virus strains were determined and
the phylogenetic relationships analyzed.
RESULTS
The complete nucleotide sequences of the eight WN
virus strains analyzed in this report (MD 2000-crow265,
NJ 2000-MQ5488, NY 2000-grouse3282, NY 2000-crow
3356, NY 1999-equine, Italy 1998-equine, Romania 1996-
MQ, and Egypt 1951; see Materials and Methods for
strain description and isolation history) were determined
as previously described, and the sequences were sub-
mitted to GenBank (Lanciotti et al., 1999). The percentage
of nucleotide and amino acid identity over the entire
genome among these strains, along with seven other
previously published complete WN genomes, is shown
in Table 1. The eight WN viruses isolated in the United
States in 1999 and 2000 display a high degree of se-
quence conservation, with a percentage nucleotide iden-
tity of 99.8% and an amino acid identity of 99.9%. The
WN virus isolated in Israel in 1998 is very closely related
to the WN viruses circulating in the United States
(99.7% nucleotide identity and 99.7% amino acid
identity). Kunjin virus, now described as a subtype of WN,
is more closely related to lineage 1 WN strains (87%
nucleotide identity) than to the Uganda 1937 WN virus
(75.7% nucleotide identity). The Uganda 1937 virus dem-
onstrates the greatest percentage difference from all
other WN strains (76% nucleotide identity), which is
supported by phylogenetic analysis which places this
virus into a separate lineage (lineage 2; see below).
A description of the amino acid substitutions between
the 15 WN viruses included in Table 1 is displayed in
Table 2; note that only the total number of differences
between Kunjin, Uganda 1937, and NY99-flamingo is in-
cluded for comparison (a detailed listing is available
upon request). WN virus strains isolated in the United
States in 1999 and 2000 demonstrate a high degree of
amino acid conservation; the maximum number of amino
acid differences observed between any two strains was
3 (incorporating the corrections for NY 1999-human). A
summary of the number of amino acid substitutions that
are unique to the Uganda 1937 WN virus, displayed by
gene, is shown in Table 3. The percentage amino acid
identity varies throughout the genome, with NS2b dis-
playing the highest degree of identity (99.2%), while the
capsid and NS2a genes demonstrated the highest se-
quence divergence (90%).
Alignment of the nucleic acid and amino acid se-
quences of the eight newly sequenced WN strains along
with seven previously published WN strains revealed
that the NY 1999-human WN virus (HNY1999, Accession
No. AF202541) displayed a higher degree of variance
within NS1 with respect to all other WN strains (Table 2).
Of interest was the clustering of four unique amino acid
substitutions within the NS1 gene at NS1 positions 7, 9,
78, and 174. To verify these mutations, we performed
sequencing of the NS1 gene of this same human strain
along with two additional human WN strains obtained
from case patients in New York who died in 1999, using
in all cases DNA amplified directly from brain tissue (not
a viral isolate). In all three cases, the sequence data of
the NY 1999-human strain in GenBank could not be
TABLE 1
Percentage Identity over the Entire Genome among WN Virus Strainsa
Nucleic acid
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 MD 2000-crow265 99.9 99.8 99.8 99.9 99.9 99.9 99.8 99.7 96.4 96.4 96.6 95.3 86.7 76.3
2 NJ 2000-MQ5488 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.7 96.4 96.4 96.6 95.3 86.8 76.4
3 NY 2000-grouse3282 99.9 99.9 99.8 99.9 99.9 99.8 99.8 99.7 96.3 96.3 96.5 95.3 86.7 76.4
4 NY 2000-crow3356 99.9 100 99.9 99.9 99.9 99.8 99.8 99.7 96.4 96.3 96.5 95.3 86.7 76.3
5 NY 1999-flamingo 99.9 100 99.9 100 99.9 99.9 99.9 99.8 96.4 96.4 96.6 95.3 86.8 76.4
6 NY 1999-equine 99.9 99.9 99.9 99.9 99.9 99.9 99.9 99.7 96.4 96.3 96.5 95.3 86.7 76.4
7 CN 1999-MQ2741 99.9 99.9 99.9 99.9 99.9 99.9 99.8 99.7 96.3 96.3 96.5 95.2 86.7 76.3
8 NY 1999-humanb 99.9 100 100 99.9 100 99.9 99.9 99.7 96.3 96.3 96.5 95.2 86.8 76.3
9 Israel 1998-stork 99.7 99.7 99.7 99.7 99.7 99.7 99.7 99.7 96.3 96.2 96.4 95.2 87.8 76.3
10 Volgograd 1999-human 99.6 99.6 99.6 99.7 99.7 99.6 99.6 99.7 99.4 98.4 99.6 95.3 86.6 76.4
11 Italy 1998-equine 99.7 99.7 99.7 99.7 99.7 99.7 99.7 99.7 99.5 99.7 98.6 95.3 86.7 76.8
12 Romania 1996-MQ 99.6 99.7 99.6 99.7 99.7 99.6 99.6 99.7 99.4 99.8 99.8 95.4 86.6 76.6
13 Egypt 1951 99.5 99.6 99.5 99.6 99.6 99.5 99.5 99.6 99.3 99.4 99.5 99.5 87.2 76.7
14 Kunjin 97.6 97.6 97.6 97.6 97.6 97.6 97.6 97.6 97.4 97.6 97.6 97.7 97.7 75.7
15 Uganda 1937 93.7 93.7 93.7 93.7 93.7 93.8 93.7 93.7 93.5 93.8 93.7 93.7 94.0 93.2
Amino acid
a Percentage nucleotide identity displayed in boldface type; percent amino acid identity displayed in regular type.
b NY 1999 human data used in this comparison incorporate sequence data changes determined in this study—see text for details.
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TABLE 2
Description of Amino Acid Differences among Select WN Virusesa
Location Cons.
NY99
flam.
MD00
crow
NJ00
mq.
NY00
grous.
NY00
crow
NY99
eq.
CN99
mq.
NY99
hum.
Isr98
stork
Vol99
hum.
Ital98
eq.
Rom96
mq. Eg51 Kunb Ug37b
CAP-102 Gln Glu
ENV-93 Arg Lys
ENV-126 Ile Thr Thr Thr Thr
ENV-154 Asn Lysc
ENV-156 Ser Proc
ENV-159 Val Ile Ile Ile
ENV-176 Tyr His
ENV-364 Val Met
ENV-442 Val Ile
ENV-452 Ser Leu
NS1-7 Asp Asnd
NS1-9 Ser Thrd
NS1-17 Ser Asn
NS1-70 Ala Ser Ser Ser
NS1-78 Leu Prod
NS1-174 Ser Glyd
NS1-206 Leu Phe Phe
NS1-234 Asp Glu
NS2A-34 Met Leu
NS2A-112 Val Ala
NS2A-119 His Tyr
NS2A-165 Gly Arg
NS2A-224 Ala Thr
NS2B-82 Asp Gly
NS2B-83 Gly Glu
NS2B-103 Val Ala Ala
NS2B-107 Ile Val
NS2B-120 Val Ile
NS3-249 Pro Pro
NS3-356 Thr Ile Ile Ile Ile
NS3-440 Gly Ala
NS3-496 Leu Pro
NS3-521 Asp Glu
NS3-557 Ser Pro
NS4A-85 Ala Val Val Val Val
NS4A-141 Met Leu
NS4B-11 Ser Asn
NS4B-13 Ile Val
NS4B-23 Val Ala
NS4B-165 Thr Ala
NS4B-245 Ile Met
NS4B-249 Glu Asp Asp Asp
NS5-54 Pro Ser
NS5-177 Arg Lys
NS5-280 lysine Asn
NS5-372 Val Ala
NS5-403 Arg Lys
NS5-431 Pro Leu
NS5-860 Ala Thr
NS5-898 Thr Ile Ile
Totale 0 2 1 0 2 3 2 4 9 11 9 11 14 81 214
a Cons., consensus amino acid among WN virus strains studied; flam., flamingo; mq., mosquito; grous., ruffed grouse; eq., equine; hum., human.
b Displayed at the bottom right portion of the table are the total number of amino acid differences of Kunjin (Kun) and Uganda 1937 (Ug37) compared
to NY99-flamingo; a detailed listing of the differences is available upon request.
c Abolishes the NYS glycosylation motif.
d Amino acid data from GenBank (AF202541); data derived in this report are in agreement with the consensus.
e Total  total number of amino acid differences compared to the consensus sequence.
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verified, and the deduced amino acids at these positions
generated in our analysis were identical to all other WN
virus strains. We conclude, therefore, that the four NS1
mutations of WN NY 1999-human described in Table 2
are likely the result of sequencing artifacts and do not
reflect true changes in the genome.
Phylogenetic trees were constructed from the aligned
nucleic acid data by utilizing the entire genome, selected
genes, or an informative region of the E-glycoprotein
gene (genome positions 1402–1656) since WN sequence
data are available for a large number of strains in this
region. The tree derived from the E-glycoprotein (Fig. 1)
includes 47 WN virus strains and, as a result, provides
the greatest resolution of tree topology. Consistent with
previous reports, WN viruses are separated into two
major lineages. Lineage 1 WN viruses have a worldwide
distribution and have been isolated from the northeast-
ern United States, Europe, Israel, Africa, India, Russia,
and Australia. In contrast, lineage 2 WN viruses have
been isolated only in sub-Saharan Africa and Madagas-
car. Within lineage 1, three monophyletic clades exist; the
KUN viruses (clade 1b) and the Indian WN viruses (clade
1c) both appear as monophyletic sister clades to the
European and African WN viruses (clade 1a). All of the
US WN viruses are found as a monophyletic clade within
the European/African clade of lineage 1 along with WN
viruses that have circulated in Israel in 1998 and 1999
(Fig. 1, red). This relationship is statistically supported in
the complete genome tree (Fig. 2) where the United
States/Israel viruses are separated into a monophyletic
group by bootstrap resampling analysis (bootstrap 
100). The United States/Israel clade is most closely re-
lated to other WN viruses that have recently been iso-
lated from north Africa, Romania, Kenya, Italy, and Rus-
sia. Phylogenetic trees were also generated using both
parsimony and distance algorithms from the capsid
gene, NS5 gene, and 3 noncoding region. In all cases
the resulting trees demonstrated the same overall topol-
ogy (Fig. 3).
DISCUSSION
The data presented here support and extend previous
sequence and phylogenetic analyses of WN virus
strains, confirming that WN viruses occur in two distinct
lineages (Savage et al., 1999; Lanciotti et al., 1999; Ber-
thet et al., 1997; Scherret et al., 2001). Lineage 1 WN
viruses have a broad geographical distribution, ranging
from Australia to the United States, and can be further
subdivided into three additional clades: WN viruses from
Africa/Europe/United States/Middle East/Russia (1a),
Kunjin viruses (1b), and India WN viruses (1c) (Fig. 1).
Lineage 2 viruses have been isolated solely from sub-
Saharan Africa and Madagascar and demonstrate ap-
proximately 75% nucleotide identity with lineage 1 vi-
ruses (Table 1). Kunjin viruses are placed within lineage
1 (clade 1b), yet these viruses can be distinguished from
other lineage 1 WN viruses by monoclonal antibody
binding and cross-neutralization analysis (Savage et al.,
1999; Lanciotti et al., 1999). Similarly, the Indian WN
viruses are placed within a unique monophyletic clade
within lineage 1 (clade 1c), and these viruses can also be
distinguished from other lineage 1 viruses by serological
assays (Umrigar and Pavri, 1977). WN viruses from Ro-
mania, Italy, and Russia also form a unique subclade
within clade 1a of lineage 1, a finding statistically sup-
ported by bootstrap analysis (bootstrap value  100; Fig.
2). Finally, WN viruses from the northeastern United
States and Israel share 99.7% nucleotide identity and
also form a statistically unique subclade within clade 1a
(bootstrap value  100; Fig. 2).
Within the United States, WN viruses have undergone
minimal genetic change since their initial characteriza-
tion in 1999, with all viruses sharing 99.8% nucleotide
identity with three or fewer amino acid differences be-
tween any of the viruses. This observation is consistent
with a recent study of WN viruses from Connecticut in
which zero to two nucleotide changes were observed in
a 920-bp region (Anderson et al., 2001). Finally, the high
degree of complete genome sequence identity between
US WN viruses and those from Israel further support a
TABLE 3
Summary of Amino Acid Differences between WN Uganda 1937 or Kunjin and All Lineage 1 WN Virusesa
Gene CAP PrM M ENV NS1 NS2a NS2b NS3 NS4a NS4b NS5
Uganda 1937 & Lineage 1
No. of aa differences 12 4 3 23 25 23 1 23 7 21 40
% identity 90.2 95.7 96.0 95.4 92.9 90.0 99.2 96.3 95.3 91.8 95.6
Kunjin & Lineage 1
No. of aa differences 4 4 2 11 10 0 1 9 3 6 10
% identity 96.8 95.7 97.3 97.8 97.2 100.0 99.2 98.6 98.0 97.7 98.9
a WN gene abbreviations: CAP, capsid; PrM, premembrane; M, membrane; ENV, envelope; NS, nonstructural (i.e., NS1, nonstructural 1).
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previous report which concluded that WN virus was
likely introduced into the United States from the Middle
East—very likely from Israel (Lanciotti et al., 1999).
A review of the existing data describing the natural
history of WN virus reveals that lineage 2 viruses appear
to be less virulent for humans (Table 4). Notably, most of
the lineage 1 WN viruses have been isolated from epi-
demics in which encephalitis and mortality were promi-
nent features. Lineage 1 viruses have also been associ-
ated with epizootics with high mortality primarily among
equines and birds. In contrast, all of the lineage 2 viruses
were isolated from asymptomatic or mild febrile humans.
In some cases, lineage 2 viruses were isolated inciden-
tally during investigations looking for other pathogens
such as hepatitis or yellow fever viruses; this was the
case when the original WN virus was isolated in Uganda
(Smithburn et al., 1940). Preliminary research using a
mouse model does in fact show a difference in neuroin-
vasiveness between some lineage 1 and lineage 2 vi-
ruses (Beasley and Barrett, 2001). There has also been
speculation about virulence differences between Euro-
pean strains of WN virus (Romania 1996-MQ, Italy 1998-
FIG. 1. Phylogenetic tree generated by parsimony analysis (PAUP) of aligned nucleotide sequences of 47 WN virus strains and 1 Japanese
encephalitis virus (used as the outgroup). The tree was constructed by utilizing a 255-bp region of the envelope gene (positions 1402–1656). Boldface
lines are used to denote the lineages (1 and 2) and clades (1a, 1b, and 1c). The US/Israel clade is displayed in red. Horizontal line lengths are not
related to sequence distances.
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equine, and Volgograd 1999-human) and those strains
associated with the outbreaks in North America and
Israel, based on the ability of the latter two viruses to
cause mortality in birds—particularly members of the
family Corvidae. While there has not yet been laboratory
confirmation of virulence differences, the recent Euro-
pean WN virus outbreaks were not reportedly associated
with bird mortality (Prilipov et al., 2001; Lanciotti et al.,
1999; Cantile et al., 2000; Tsai et al., 1998). A comparison
of the amino acid sequences for these European WN
isolates reveals six amino acid changes consistent with
the geographic origin of viruses: two in the E-protein
[E-126; Ile3 Thr and E-159 (Italy 1998 and Romania 1996
only); Val3 Ile], one in NS1 (NS1-70; Ala3 Ser), one in
NS3 (NS3-356; Thr3 Ile), one in NS4A (NS4A-85; Ala3
Val), and one in NS4B (NS4B-249; Glu 3 Asp) (Table 2).
Of these amino acid changes, only the regions at or near
E-protein amino acids 126 and 159 have been associated
with phenotypic changes. It is noteworthy that there are
no amino acid differences observed among both the
European and US WN viruses within the pre-M and M
proteins. However, Kunjin and Uganda 1937 display a
number of amino acid substitutions in these genes with
respect to all other WN strains, six and seven, respec-
tively (Table 3).
The amino acid 126 region is one of two primary
Domain II-binding sites for virus neutralizing antibodies
to yellow fever and MVE viruses (Lobigs et al., 1987;
McMinn et al., 1995). The amino acid 159 region has
been associated with flavivirus attenuation (Ryman et al.,
1997). Although the observed E-glycoprotein changes of
E-154, Asn 3 Lys in the Volgograd 1999 isolate and
E-156, Ser3 Pro in the Egypt 1951 isolate are not shared
by the other European WN viruses, both of these
changes result in the ablation of a potential E-protein
glycosylation acceptor motif—NYS. Glycosylation at this
FIG. 2. Phylogenetic tree generated by parsimony algorithm (PAUP) with bootstrap resampling analysis (500 iterations) of aligned nucleotide
sequences of 15 WN virus strains. The tree was constructed by utilizing the complete genomic sequence of 15 WN virus strains; the numbers
displayed to the left of the nodes are the bootstrap percentages for the clades supported to the right. Lineages are shown by numbers and brackets
on the right and clades are designated by 1a and 1b. Horizontal line lengths are not related to sequence distances.
101PHYLOGENETIC ANALYSIS OF WEST NILE VIRUSES
motif is believed to be important in stabilizing the E-pro-
tein conformation in low-pH environments (Rey et al.,
1995). Modifying this motif by passing WN virus in inver-
tebrate cells resulted in viral attenuation (Chambers et
al., 1998). Altering this motif by passing dengue 2 virus in
the presence of ammonium chloride or at low pH re-
sulted in mutants with changed virus-mediated cell
membrane fusion characteristics (Guirakhoo et al., 1993;
Johnson et al., 1994). Both of these regions are also
spatially proximal to attenuating mutations for JE virus
(Monath et al., 1999; Nitayaphan et al., 1990). Clearly,
both in vitro and in vivo virulence studies will be neces-
FIG. 3. Phylogenetic trees generated by parsimony analysis (PAUP) of aligned nucleotide sequences of 15 WN virus strains. The trees were
constructed by utilizing the capsid gene (A), NS5 gene (B), or the 3 noncoding region of the genome (C). Lineages are shown by numbers and
brackets on the right. Horizontal line lengths are proportional to the sequence distances; the scale is shown in the lower left portion of the figures.
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sary to confirm and further characterize these prelimi-
nary observations of virulence differences between the
viruses.
MATERIALS AND METHODS
All WN virus strains sequenced in this study were
obtained from the reference collection maintained at the
Division of Vector-Borne Infectious Diseases, Centers for
Disease Control and Prevention, Fort Collins, Colorado.
The isolation history and sequence description of the
WN virus strains Egypt 1951 (Eg101; Accession No.
AF260968), Romania 1996-MQ (RO97-50, Culex pipiens,
Bucharest, Romania; Accession No. AF260969), Italy
1998-equine (PaAn981, Tuscany, Italy; Accession No.
AF404757), New York 1999-flamingo (382-99; Accession
No. AF196835), New York 1999-equine (eqhs; Accession
No. AF260967), Volgograd 1999-human (Accession No.
FIG. 3—Continued
TABLE 4
West Nile Virus Strains and Disease Associations
WN virus strain Source Disease association (reference)
Genetic
lineage
Egypt 1951 Human Mild febrile (Melnick et al., 1951) 1
Israel 1952 Human Encephalitis (Pruzanski and Altman, 1962) 1
France 1965 Human Encephalitis-human/equine (Price and O’Leary, 1967) 1
South Africa 1974 ?? Febrile (Hayes, 1989) 1
India 1980 Human Encephalitis (George et al., 1984) 1
Romania 1996 Human/mosquito Encephalitis (Tsai et al., 1998) 1
Italy 1998 Equine Encephalitis-equine (Cantile et al., 2000) 1
Israel 1999 Human Encephalitis-human/equine/avian (Giladi et al., 2001) 1
New York 1999 Human/equine Encephalitis-human/equine/avian (Lanciotti et al., 1999) 1
Volgograd 1999 Human Encephalitis (Prilipov et al., 2001) 1
Kunjin 1960 Mosquito Encephalitis (Scherret et al., 2001) 1
Uganda 1937 Human Mild febrile (Smithburn et al., 1940) 2
Central African Republic 1972 Mosquito/avian None 2
Central African Republic 1983 Human Hepatitis (Georges et al., 1987) 2
Madagascar 1986 Mosquito Mild febrile (Monath and Heinz, 1996) 2
Senegal 1990 Mosquito None (V. Deubel, personal communication) 2
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AF317203), NY 1999-human (Accession No. AF202541),
CN 1999-MQ2741 (Accession No. AF206518), Israel 1998-
stork (Accession No. AY033389), Kunjin (Accession No.
D00246), and Uganda 1937 (Accession No. M12294)
have been published elsewhere (Savage et al., 1999;
Prilipov et al., 2001; Lanciotti et al., 1999; Trock et al.,
2001; Cantile et al., 2000). The WN virus 2000 strains
were isolated in Vero cells as previously described (Sav-
age et al., 1999). WN MD 2000-crow265 was isolated
from an American crow, Baltimore County, Maryland (Ac-
cession No. AF404753); WN NJ 2000 MQ5488 was iso-
lated from a pool of C. pipiens, Bergen County, New
Jersey (Accession No. AF404754); WN NY 2000-
grouse3282 was isolated from a ruffed grouse, Oswego
County, New York (Accession No. AF404755); and WN NY
2000-crow3356 was isolated from a crow, Rockland
County (Staten Island), New York (Accession No.
AF404756). RT-PCR amplification and nucleic acid se-
quencing were performed as previously described, and a
complete list of the sequencing primers utilized is avail-
able upon request (Lanciotti et al., 1999). The nucleic
acid sequences derived from each of the WN strains
were aligned with one another and with seven previously
published WN strains obtained from GenBank using the
alignment algorithm ClustalW within MegAlign (version
5.01; DNASTAR, Madison, WI). The aligned nucleic acid
sequences were used to construct phylogenetic trees
using the parsimony-based algorithm within PAUP (heu-
ristic search; version 4.0, Sinauer, Sunderland, MA). Phy-
logenetic trees were also constructed using distance-
based algorithms within PAUP; the resulting trees dis-
played nearly identical topology to the parsimony-based
trees (trees not shown).
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